19
Ironshore Pharmaceuticals, based in U.S.A, is a pharmaceutical company.
One of their notable products is METHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 209311.
Regulatory Information RX
With a dosage strength 100MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2018-08-08
18
Ironshore Pharmaceuticals, based in U.S.A, is a pharmaceutical company.
One of their notable products is METHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 209311.
Regulatory Information RX
With a dosage strength 60MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2018-08-08
17
Ironshore Pharmaceuticals, based in U.S.A, is a pharmaceutical company.
One of their notable products is METHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 209311.
Regulatory Information RX
With a dosage strength 20MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2018-08-08
16
Ironshore Pharmaceuticals, based in U.S.A, is a pharmaceutical company.
One of their notable products is METHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 209311.
Regulatory Information RX
With a dosage strength 80MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2018-08-08
15
Ironshore Pharmaceuticals, based in U.S.A, is a pharmaceutical company.
One of their notable products is METHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 209311.
Regulatory Information RX
With a dosage strength 40MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2018-08-08